CD8A and neoplasm: Intraperitoneal administration of anti-CD4 or anti-CD8 depletion antibodies or IgG isotype control antibody was started a day before MBT-2 tumor inoculation, and oral administration of B. longum 420 was started 7 days after the tumor inoculation (Figure 4A).